Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/1999
12/15/1999CN1238455A Diluent and cleaning liquid for blood analysis counter
12/15/1999CN1238454A Compound and its use
12/15/1999CN1238218A Pigment marked polymerization antibody and preparation method thereof
12/15/1999CN1047444C Method and apparatus for determining concentrations of carbon, hydrogen and nitrogen and molten steel
12/15/1999CA2274736A1 Atmospheric analysis facility
12/15/1999CA2273683A1 Diagnostic markers for human disorders
12/14/1999US6002954 Detection of biological molecules using boronate-based chemical amplification and optical sensors
12/14/1999US6002475 Spectrophotometric analytical cartridge
12/14/1999US6002007 Special chemiluminescent acridine derivatives and the use thereof in luminescence immunoassays
12/14/1999US6002000 Chemiluminescent compounds and methods of use
12/14/1999US6001988 High affinity nucleic acid ligands to lectins
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001978 Antibody that immunoreacts with human tissue factor heavy chain protein; for immunoassay diagnosis of thrombus and thrombosis and for neutralizing the factor
12/14/1999US6001975 Antibody which specifically binds to a human leukocyte antigen precursor; antitumor/anticarcinogenic agents
12/14/1999US6001973 Antagonists of interleukin-15
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001968 Mammalian obese polypeptide; for use in genetic therapy; for the treatment of mammals to control body weight and fat content in mammals; for the detection of modulators of weight control
12/14/1999US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/14/1999US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/14/1999US6001659 Assays using chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
12/14/1999US6001658 Test strip apparatus and method for determining presence of analyte in a fluid sample
12/14/1999US6001657 Antibodies that selectively bind quadruplex nucleic acids
12/14/1999US6001656 Method for the detection of creatinine
12/14/1999US6001655 Measuring meat smoothness: determining stress relaxation and one or more physical parameters, recovering sensory data on sample, quantifying and comparing smoothness data, determine energy dissipation; quick and effective testing of meat
12/14/1999US6001654 Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001621 Protein tyrosine kinases
12/14/1999US6001619 Recombinantly produced synthetase polypeptide or fragment which catalyzes ubiquitin conjugation; screening modulators of cell cycle and producing cells with defects in mitotic cycle; detecting cell propagation defects
12/14/1999US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999US6001583 Contacting cell having complex of shc polypeptide/grb-7 adaptor polypeptide with compound that acts intracellularly to disrupt the complex; for prevention, prognostic evaluation, and treatment of cancer especially breast cancer
12/14/1999US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999US6001580 Detecting the activated isoform of mitogen activated kinase; contacting sample with an antibody which binds an amino acid sequence, contacting sample with second antibody, detecting active isoform which specifically binds to both antibodies
12/14/1999US6001579 Supports and combinatorial chemical libraries thereof encoded by non-sequencable tags
12/14/1999US6001577 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
12/14/1999US6001573 Mixing porphyrin with particles, separating porphyrin laheled particles from unbound particles, detecting labeled particles; without using bridging agent
12/14/1999US6001571 Hybridizing denatured sample with nucleic acid probes attached to surface of particles having transponders with memory elements, analyzing particles to detect presence of label, decoding data using dedicated read/write scanner
12/14/1999US6001567 Detection of nucleic acid sequences by invader-directed cleavage
12/14/1999US6001563 Detecting a substance which sensitizes cell to therapeutic agent; contacting transfected cell with drug in vitro, determining resistance to drug, detecting sensitizer; for reversing drug resistance in cells; anticarcinogenic agents
12/14/1999US6001561 Indicator reagents for assays using chemiluminescent electron-rich aryl substituted 1,2-dioxetanes
12/14/1999US6001560 Stably-transformed human cell lines containing a human gamma interferon-responsive human hla-dr alpha promoter operatively linked to a reporter gene for use in screening for agonists or antagonists of human gamma interferon
12/14/1999US6001558 Amplification and detection of HIV-1 and/or HIV 2
12/14/1999US6001556 Polymeric assay film for direct colorimetric detection
12/14/1999US6001553 Saccharomyces cell engineered to express chimeric human signal transduction enzyme and g protein; for detection of enzyme inhibitors or activators
12/14/1999US6001499 Fuel cell CO sensor
12/14/1999US6001370 New attenuated strain allows the obtaining of vaccines and diagnostic kits which make possible both the early diagnosis of porcine reproductive respiratory syndrome and an efficient preventive treatment of such disease
12/14/1999US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/14/1999US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999US6001359 For the detection and treatment of carcinomas derived from the gastrointestinal tract and pancreatic duct
12/14/1999US6001331 Introducing into patient benzylthiazol-3-ium derivatives of given formula; allowing time for compound to associate with amyloid; detecting the labeled compound associated with amyloid deposits
12/14/1999US6001239 A reagent capable of reacting with the analyte to produce a measurable change in potential which can be correlated to the concentration of the analyte in fluid sample
12/14/1999US6001229 Miniature instrumentation for electrically controlled manipulation of fluid for capillary electrophoresis, liquid chromatography, and flow injection analysis
12/14/1999US6001228 Device for performing measurements in fluids
12/14/1999US6000279 Rubber testing
12/14/1999US6000274 Method for automatically detecting total hydrocarbon content and individual volatile organic compound concentrations of waste gas
12/14/1999CA2185555C Integrated system for biological fluid constituent analysis
12/14/1999CA2117795C Gustducin materials and methods
12/14/1999CA2116341C Needleless injector
12/14/1999CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999CA2065150C Inhibitors of thrombin
12/14/1999CA2062757C Measuring apparatus and method
12/14/1999CA1340848C Pseudorabies virus protein
12/14/1999CA1340847C Adhesin antigens
12/12/1999CA2272599A1 Rice gene resistant to blast disease
12/09/1999WO1999063369A1 Flow cell
12/09/1999WO1999063350A1 Method for detecting a neuropathology by measuring apolipoprotein d
12/09/1999WO1999063349A1 Method for detecting infection-phase-specific antibodies
12/09/1999WO1999063348A1 Analytical method using multiple virus labelling
12/09/1999WO1999063347A2 Electrochemical based assay processes, instrument and labels
12/09/1999WO1999063346A1 Method and device for electrochemical immunoassay of multiple analytes
12/09/1999WO1999063345A1 Method for detecting analytes
12/09/1999WO1999063344A1 Homogeneous biospecific assay using a solid phase, two-photon excitation and confocal fluorescence detection
12/09/1999WO1999063343A1 Method for detecting potential cellular toxicity of compounds
12/09/1999WO1999063342A1 Method for staining biological specimens by combining unstable reagents on a microscope slide
12/09/1999WO1999063341A2 Use of oxidative stress diagnostic plot as a health indicator for assessing oxidative stress and its control in humans
12/09/1999WO1999063340A1 Process for the determination of mtbe in the ground and air
12/09/1999WO1999063333A1 Surface regeneration of biosensors
12/09/1999WO1999063329A1 Optical amplification of molecular interactions using liquid crystals
12/09/1999WO1999063326A1 Evanescent-wave excitation of upconverting labels
12/09/1999WO1999063116A2 Use of prothymosin in the diagnosis and treatment of endometriosis
12/09/1999WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999WO1999063109A1 Method for determining antigens
12/09/1999WO1999063107A1 Non-viable cell preparation and assay reagent
12/09/1999WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection
12/09/1999WO1999063094A2 Nucleotide and protein sequences of gpr1 and methods based thereon
12/09/1999WO1999063093A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999WO1999063089A1 Cyclin e2 genes and proteins
12/09/1999WO1999063087A1 G-protein coupled receptor, named 2871 receptor
12/09/1999WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999WO1999063079A1 Endometriosis-associated gene
12/09/1999WO1999063075A1 Monoclonal antibodies and method for assaying fdp
12/09/1999WO1999062946A1 nrdF
12/09/1999WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999WO1999062926A1 Multiparametric fluorescence in situ hybridization
12/09/1999WO1999062925A1 Angiopoietin related gene sequence scarface 1
12/09/1999WO1999062919A1 Redox reversible bipyridyl osmium complex conjugates
1 ... 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 ... 3937